Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients

類似資料

• Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
  著者:: Alobaid, Abdulaziz S., 等
  出版事項: (2016)
• Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients
  著者:: Alobaid, Abdulaziz S., 等
  出版事項: (2016)
• Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults
  著者:: Pai, Manjunath P.
  出版事項: (2016)
• Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds
  著者:: Udy, Andrew A, 等
  出版事項: (2014)
• Pharmacokinetics of Clindamycin in Obese and Nonobese Children
  著者:: Smith, Michael J., 等
  出版事項: (2017)